Citeline

What Citeline does

Citeline is a privately held provider of clinical trial, drug pipeline, regulatory, and commercial intelligence serving the global pharmaceutical, biotechnology, CRO, and medical technology industries. The company's core technology stack combines proprietary real-world data, curated clinical and commercial databases, and AI-enabled analytical modules — including Protocol SmartDesign, Investigator SmartSelect, Cohort SmartBuilder, and the newly launched Disclosure Alignment Risk Index (DARI) — to support evidence-based decisions across the clinical development lifecycle. Underlying data assets span 400,000+ clinical trials, 96,000+ drugs, 26,000+ companies, 1,600+ diseases, 535,000+ investigators, and 185+ country trial site coverage, maintained by 500+ subject matter experts and built over 30 years of continuous pipeline tracking.

Citeline operates a subscription-based enterprise revenue model, selling quote-priced platform access (Pharmaprojects+, Trialtrove+, Sitetrove+, TrialScope Disclose, Citeline Connect, PatientMatch) and ancillary consulting services (Feasibility as a Service, Ask the Analyst, Pharma Ignite marketing) to 3,000+ organizations including the top 10 global pharma companies and major CROs. Distribution is enterprise-led through direct field sales and embedded within the broader Norstella portfolio (Evaluate, MMIT, Panalgo, Skipta, Dedham Group), with top-of-funnel demand generation supported by long-running proprietary media brands including Scrip (since 1972), Pink Sheet, In Vivo, Generics Bulletin, Medtech Insight, and HBW Insight. Citeline became part of Norstella in November 2022 when the group was formed as a $5 billion global pharmaceutical technology company.

The company is headquartered in New York with a registered UK operating entity (Pharma Intelligence UK Limited) in London, and maintains commercial presence across the US, UK, Japan, Switzerland, and China. Recent strategic activity is concentrated in AI-driven product development and integration partnerships: three core-tier alliances were signed in Q1 2026 with Risklick (protocol design), Evinova (AI-native study design), and Recursion (ClinTech drug discovery). Earlier inorganic activity includes the acquisition of Clinerion in January 2023, which expanded real-world data and patient network capabilities now surfaced through Cohort SmartBuilder.

Name

Citeline

Legal name

Pharma Intelligence UK Limited

Website

https://citeline.com

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

251–500 employees

Short description

Citeline is a global clinical trial, drug pipeline, and regulatory intelligence provider serving 3,000+ pharma, biotech, CRO, and medtech organizations with AI-enabled subscription databases, disclosure compliance tools, and 30 years of curated real-world data.

Ownership category

akta.pro rank

Product category

Pharmaceutical and Clinical Trial Intelligence

NAICS

Scientific Research and Development Services (5417), Marketing Research and Public Opinion Polling (541910), Other Management Consulting Services (541618)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Site & Investigator Platforms (Site Payments, Feasibility, Activation) (HLACAOAJ)

akta.pro secondary industry

Medical & Clinical Reference (Physicians, Nursing, Allied Health) (EDAGAGAA)

Keywords

• Pharmaceutical intelligence
• Clinical trial intelligence
• Drug pipeline tracking
• Real-world data analytics
• Regulatory compliance solutions

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Others

Revenue model

1. Subscription-based Intelligence Services: Recurring subscription model providing access to pharmaceutical intelligence databases and platforms including Pharmaprojects, Trialtrove, Sitetrove, and analytics tools. Services support clinical planning, regulatory compliance, and commercial decisions for life sciences organizations.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels9 records

Core offering

Citeline provides subscription-based pharmaceutical and medtech business intelligence, including AI-powered clinical trial databases (Pharmaprojects+, Trialtrove+, Sitetrove+), the SmartSolutions suite for protocol design, site selection, and patient cohort planning, TrialScope Disclose for regulatory compliance, patient engagement platforms (Citeline Connect, PatientMatch), and industry-leading publications (Scrip, Pink Sheet, In Vivo). It sells these data, software, and consulting solutions primarily to pharmaceutical, biotech, CRO, and medtech customers via enterprise contracts.

Product overview

Citeline offers a comprehensive suite of complementary business intelligence offerings organized as an integrated platform with specialized modules. The core portfolio centers on AI-powered SmartSolutions (Protocol SmartDesign, Investigator SmartSelect, Cohort SmartBuilder), clinical trial intelligence databases (Trialtrove+, Sitetrove+), and drug pipeline tracking (Pharmaprojects+). The regulatory and compliance suite includes TrialScope Disclose and the new Disclosure Alignment Risk Index (DARI). Patient engagement solutions encompass Citeline Connect and PatientMatch. Commercial intelligence is delivered through established publications including Scrip, Pink Sheet, and In Vivo, alongside pharmacy data services (C+D Data). The platform integrates data across clinical, commercial, and regulatory domains to accelerate the connection of treatments to patients.

Differentiator

Problem solved

Functional benefit

Brands

• Pharmaprojects+: AI-powered drug pipeline intelligence with enhanced analytics
• Trialtrove+
• Sitetrove+
• SmartSolutions
• TrialScope Disclose
• Citeline Connect
• Pink Sheet
• Scrip
• In Vivo
• Pharma Ignite
• Chemist + Druggist (C+D)

Products and services

• SmartSolutions Suite AI-powered clinical trial optimization platform combining Protocol SmartDesign, Investigator SmartSelect, and Cohort SmartBuilder to improve protocol design, site selection, and patient recruitment, delivering documented 30-60% enrollment improvements for pharma and CRO customers.
• Pharmaprojects+ Comprehensive drug pipeline intelligence database tracking 96,000+ drugs and pharmaceutical R&D activity globally, providing intelligence on drug candidates and therapeutic area trends for pharma, biotech, and investor customers.
• Trialtrove+ Clinical trial intelligence database providing data on 400,000+ global clinical trials with AI-enhanced analytics, supporting trial planning, feasibility assessment, and site selection for pharma and CRO customers.
• Sitetrove+ Investigator and trial site database covering 535,000+ clinical trial investigators and sites across 185+ countries, with AI capabilities for optimized site selection and investigator identification.
• TrialScope Disclose Clinical trial disclosure management platform helping sponsors maintain compliance with global disclosure requirements, track trial transparency, and manage regulatory submissions.
• Citeline Connect Patient recruitment and engagement platform connecting patients with clinical trials through community portals, education resources, and provider networks.
• Citeline PatientMatch AI-powered patient matching solution that identifies and matches eligible patients with relevant clinical trial opportunities.
• Disclosure Alignment Risk Index (DARI) AI-enabled framework that scores clinical trial disclosure alignment across SEC filings, registries, press releases, and presentations, identifying risks in timing, accuracy, consistency, governance, and tone.
• Scrip Pharma news and expert analysis publication covering commercial strategy, deal-making, clinical trial results, and market access for pharma decision-makers since 1972.
• Pink Sheet Regulatory intelligence publication providing in-depth analysis of pharma regulatory policy, FDA approvals, and global regulatory landscape.
• In Vivo Commercial and strategic intelligence publication covering pharma deals, financing, market analysis, and strategic insights for industry professionals.
• C+D Data UK pharmacy data platform providing dispensing data, market intelligence, and analytics for the pharmacy sector.
• Global Patient Insights Global patient population data service providing insights for clinical trial planning across therapeutic areas and geographic regions.
• TrialScope Intelligence Clinical trial intelligence platform supporting disclosure compliance, regulatory strategy, and transparency requirements management.
• Pharma Ignite Marketing insights and analytics division delivering thought leadership, lead generation, awareness campaigns, and market analysis for pharma and life sciences clients.
• Feasibility as a Service Clinical trial feasibility assessment service providing data-driven insights for study design, site selection, and patient recruitment strategy.

Quantifiable outcome

• 30-60% improvements in trial enrollment from ClinTech platform investments
• +3 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature6 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Recursion PharmaceuticalscoreTechnology or Integration · 31 March 2026Expanded strategic partnership integrating Citeline's real-world data and evidence capabilities into Recursion's AI-driven ClinTech platform for drug discovery and development. The platform integration combines multimodal datasets, AI models, and experimental biology to improve clinical trial design and execution. Demonstrated 30-60% improvements in trial enrollment from ClinTech platform investments.
• EvinovacoreTechnology or Integration · 26 February 2026Multi-year partnership integrating Citeline's clinical trial intelligence databases into Evinova's AI-native Study Designer platform. The collaboration enables data-driven optimization of clinical study design through combined capabilities in clinical trial intelligence and AI-powered study development.
• RisklickcoreStrategic or Co-development Partner · 13 January 2026Strategic partnership to develop an integrated AI-driven solution for clinical trial protocol development, covering design, authoring, operationalization, and regulatory disclosure. Addresses rising protocol amendment costs ($140,000-$500,000 each) by combining Risklick's protocol design expertise with Citeline's data and AI capabilities for evidence-based optimization.
• NorstellaLinQcoreTechnology or Integration · 14 November 2025Integration of NorstellaLinQ real-world data into Citeline's Cohort SmartBuilder tool for clinical planning teams. Provides real-time visibility into patient populations for designing more feasible and diverse clinical trials.
• XtalksminorGTM or Marketing Partner · 31 March 2025Co-hosted webinar on precision feasibility and real-world data for clinical trial site selection and patient recruitment. Joint educational content focused on improving patient recruitment through data-driven insights.
• NorstellacoreOthersCiteline became part of Norstella in November 2022. Norstella consists of market-leading pharmaceutical solutions providers united under one goal: to improve patient access to life-saving therapies. Within Norstella, Citeline plays a key role in helping clients connect the dots from pipeline to patient.

Scale indicators12 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• IQVIA: IQVIA is the largest life sciences technology and services company, combining clinical trial technology, real-world data, and CRO services. It competes with Citeline across clinical trial intelligence, RWD, and AI-driven trial design while bundling intelligence with execution capabilities that Citeline alone cannot match.
• Oracle Health Sciences: Oracle Health Sciences (built on the former Cerner and Phase Forward/Inform acquisitions) offers clinical trial management, EDC, safety, and real-world data analytics. It competes with Citeline's Trialtrove, Sitetrove, and protocol design modules at large pharma customers and bundles data with broader Oracle cloud infrastructure.

Direct peers

• Veeva Systems: Veeva is a leading cloud software provider for life sciences with deep penetration into clinical operations (Veeva Vault Clinical, Veeva eTMF) and commercial suites. It overlaps directly with Citeline's clinical trial planning, regulatory, and quality/compliance offerings and is a primary competitor for enterprise pharma IT budgets.
• Medidata (Dassault Systèmes): Medidata, a Dassault Systèmes brand, is a leading clinical trial technology platform spanning EDC, eCOA, randomization, and trial design. It directly competes with Citeline's clinical trial planning and site/investigator intelligence and increasingly overlaps in AI-driven trial design and patient-centric trial operations.
• GlobalData: GlobalData provides syndicated intelligence on pharma, clinical trials, and medical devices through databases, reports, and analytics. It competes with Citeline's Pharmaprojects drug pipeline intelligence, Trialtrove trial intelligence, and commercial/regulatory insight products for pharma and medtech subscribers.
• Informa Pharma Intelligence: Informa's Pharma Intelligence offers clinical trial, drug development, and market access intelligence including Citeline's former competitor brands (TrialTrove before Informa exits). It competes directly with Citeline's subscriptions, news publications, and analytics across pharma R&D and commercial strategy.
• Evaluate (Norstella): Evaluate, a sibling Norstella brand, provides commercial intelligence on pharma including forecasts, consensus estimates, and deal data. It is highly comparable to Citeline's commercial publications and Pharmaprojects and represents the most direct internal cross-sell/overlap peer.
• Panalgo (Norstella): Panalgo, also under Norstella, provides advanced analytics and real-world data analytics for pharma and healthcare. It intersects with Citeline's AI analytics, Cohort SmartBuilder, and real-world data capabilities, making it a close portfolio peer for analytics-driven clinical and commercial use cases.

Emerging players

• Definitive Healthcare: Definitive Healthcare provides intelligence on healthcare providers, sites, and life sciences commercial activity. It overlaps with Citeline's HCP/site intelligence (Sitetrove) and is increasingly extending into pharma and biotech commercial analytics, making it an emerging adjacent competitor.
• TriNetX: TriNetX operates a global health research network that aggregates real-world patient data for clinical trial feasibility, site selection, and cohort discovery. It is an emerging competitor to Citeline's Sitetrove, Investigator SmartSelect, and Cohort SmartBuilder, particularly for RWD-driven trial planning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/citeline
• YouTubeyoutube.com/@CitelineYouTube
• LinkedInlinkedin.com/company/citeline
• Facebookfacebook.com/citeline

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Citeline